Long-term Safety and Tolerability of Alirocumab (SAR236553/REGN727) Versus Placebo on Top of Lipid-Modifying Therapy in High Cardiovascular Risk Patients With Hypercholesterolemia (ODYSSEY Long Term)
Clinical trial NCT01507831 · COMPLETED
Trial details
- NCT number
- NCT01507831
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-01-01
- Primary completion
- 2014-11-01
- Enrollment
- 2341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.